Quantitative Prediction of OATP-Mediated Drug-Drug Interactions With Model-Based Analysis of Endogenous Biomarker Kinetics-Reference-Cited by-同舟云学术

Quantitative Prediction of OATP-Mediated Drug-Drug Interactions With Model-Based Analysis of Endogenous Biomarker Kinetics

Published:2018-08 Issue:8 Volume:7 Page:517-524
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Yoshida Kenta¹,Guo Cen¹²,Sane Rucha¹

Affiliation:

1. Clinical Pharmacology, Genentech Research and Early Development; South San Francisco California USA

2. Eshelman School of Pharmacy; University of North Carolina at Chapel Hill; Chapel Hill North Carolina USA

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/psp4.12315/fullpdf

Reference36 articles.

1. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) In Vitro Metabolism- and Transporter-Mediated Drug-Drug Interaction Studies http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm064982.htm 2017

2. Ministry of Health, Labour, and Welfare, Japan Guideline of drug interaction studies for drug development and appropriate provision of information http://search.e-gov.go.jp/servlet/Public?CLASSNAME5PCMMSTDETAIL&id5495170159 2017

3. European Medicines Agency Guideline on the Investigation of Drug Interactions http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/07/WC500129606.pdf 2013

4. Comparing various in vitro prediction criteria to assess the potential of a new molecular entity to inhibit organic anion transporting polypeptide 1B1;Vaidyanathan;J. Clin. Pharmacol.,2016

5. Clin. Pharmacol. Ther 99

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration;Clinical Pharmacokinetics;2024-02-29

2. Building a Predictive PBPK Model for Human OATP Substrates: a Strategic Framework for Early Evaluation of Clinical Pharmacokinetic Variations Using Pitavastatin as an Example;The AAPS Journal;2024-01-05

3. Utility of Coproporphyrin-I Determination in First-in-Human Study for Early Evaluation of OATP1B Inhibitory Potential Based on Investigation of Ensitrelvir, an Oral SARS-CoV-2 3C-Like Protease Inhibitor;Journal of Pharmaceutical Sciences;2023-09

4. Physiologically-Based Pharmacokinetic Modeling of PAXLOVID™ with First-Order Absorption Kinetics;Pharmaceutical Research;2023-05-25

5. Progress in the Quantitative Assessment of Transporter-Mediated Drug–Drug Interactions Using Endogenous Substrates in Clinical Studies;Drug Metabolism and Disposition;2023-05-11